Miguel Martín Jiménez, MD, PhD
Professor and Head of Medical Oncology Service, Hospital General Universitario Gregorio Marañon
Professor – Complutense University, Madrid, Spain
Dr. Martin is a Medical Oncologist, fully devoted to breast cancer research and treatment. He received his medical degree from the University of Valladolid and completed his fellowship and residency at the San Carlos University Hospital, Madrid. In 1989, he obtained the European Certification on Medical Oncology in London. In 1990–1991, Dr. Martin visited the Fred Hutchinson Cancer Research Center and the University of Washington Medical Center at Seattle (EEUU), where he worked on high-dose chemotherapy with bone marrow transplantation for breast cancer. As an editor of several medical journals, he was a member of the International Editorial Board of the journal Lancet Oncology, as well as other international journals (European Journal of Clinical & Medical Oncology, Cancer & Chemotherapy Reviews, etc.). In 1995, Dr. Martin created GEICAM (Spanish Group for Breast Cancer Research), a network involving more than 140 Spanish institutions.
Since its foundation, he is the Chairman of the Group. GEICAM has conducted more than 120 clinical, translational, and epidemiological studies in the field of breast cancer. Since 2001, Dr. Martin serves as a member of the Board of Directors and of the Scientific Steering Committee of TRIO, an international not-for-profit clinical research organization involving 45 different countries. Prof. Martin has published more than 400 articles in peer-reviewed medical journals. He has contributed to more than 300 presentations at international medical meetings and has presented invited lectures in several countries.
He is a full member of several scientific societies such as ASCO, ESMO, SEOM, ASBD, EBMT, ABMT, and MASCC. Dr. Martin was the Spanish representative at ESMO from 2003 to 2006. In 2006, he was appointed as European Liaison of the International Affairs Committee of ASCO. He has served as a member of the panel of the International Consensus Conference of Early Breast Cancer (St Gallen) and is currently a member of the Steering Committee of Early Breast Cancer Trialists Cooperative Group (Oxford, UK). In 2012, Dr Martin was nominated as the Advisor of the Spanish Ministry of Health. He was nominated as the Board Member of The National Committee Of The Spanish Society Medical Oncology (2013). In June 2014, he was selected as the reviewer of the ANEP. In March 2015, Dr. Martin was named Numerary Academic by the Spanish Medical Surgery Academy. From October 2015 to December 2017, Dr. Martin held the position of the President of the Spanish society of medical oncology. Dr. Martin received the prestigious 2017 ESMO Award by The European Society for Medical Oncology because of his expertise in breast cancer and his contribution to medical oncology development. He was awarded with the Premio Obieta by the Royal Spanish Academy of Medicine for the best professional career in December 2017.
News & Updates
Connect With Us
